A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2001
11/01/2001	WO2001080823A2 Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients
11/01/2001	WO2001080822A2 Effervescent granules and methods for their preparation
11/01/2001	WO2001080819A1 Cosmetic or dermatological cream composition, the preparation and the use thereof
11/01/2001	WO2001080813A2 Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
11/01/2001	WO2001080810A2 Chondroitin synthase gene and methods of making and using same
11/01/2001	WO2001080809A2 Medicament for the treatment of diseases caused by parasitic protozoa
11/01/2001	WO2001080807A2 Medicine containing polysaccharide substances for activating apoptosis
11/01/2001	WO2001080796A1 Minimizing adverse experience associated with oxybutynin therapy
11/01/2001	WO2001080715A2 Methods for identifying compounds useful for preventing acute clinical vascular events in a subject
11/01/2001	WO2001080713A2 Methods for non-permanent occlusion of a uterine artery
11/01/2001	WO2001080619A2 Pharmaceutical composition containing citalopram
11/01/2001	WO2001060381B1 Nucleoside analogs with carboxamidine-modified bicyclic base
11/01/2001	WO2001056573A8 Use of cox-2 inhibitors as gastroprokinetics
11/01/2001	WO2001044239A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
11/01/2001	WO2001042263A3 Oligosaccharide mixture
11/01/2001	WO2001042231A3 Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors
11/01/2001	WO2001041762A3 Valdecoxib compositions
11/01/2001	WO2001041761A3 Valdecoxib compositions
11/01/2001	WO2001038311A3 Pyrimidine derivatives as selective inhibitors of cox-2
11/01/2001	WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001	WO2001035974A3 Aplidine treatment of cancers
11/01/2001	WO2001034582A3 Sordaricin derivatives having antifungal activity
11/01/2001	WO2001034548A3 3-heteroatom substituted and two carbon homologs of 15-hete and methods of use
11/01/2001	WO2001033966A3 Active ingredient combination having insecticidal and acaricidal characteristics
11/01/2001	WO2001032153A3 Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
11/01/2001	WO2001030736A3 Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors
11/01/2001	WO2001030329A3 Combinations of lamivudine and entecavir for treatment of hepatitis b virus infuction
11/01/2001	WO2001029084A3 Novel human proteins and polynucleotides encoding the same
11/01/2001	WO2001029049A3 Imidazole derivatives as phosphodiesterase vii inhibitors
11/01/2001	WO2001029046A3 A salt of morphine
11/01/2001	WO2001029025A3 Tyrosine kinase inhibitors
11/01/2001	WO2001029015A3 Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
11/01/2001	WO2001028570A3 Zinc lactate lozenges and uses thereof
11/01/2001	WO2001028356A3 Food supplement for increasing lean mass and strength
11/01/2001	WO2001025187A3 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides
11/01/2001	WO2001021620A3 Amine derivatives of benzo-4,5-thieno-2,3-d pyrimidines
11/01/2001	WO2001018161A3 Process for the preparation of conjugated linoleic acid (cla)
11/01/2001	WO2001017480A3 Methods and compositions for preventing and treating urinary tract disorders
11/01/2001	WO2001014318A3 New effectors of dipeptidyl peptidase iv for topical use
11/01/2001	WO2001013924A8 Novel compositions for controlled release of a biologically active agent, and the preparation thereof
11/01/2001	WO2001013910A3 Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry
11/01/2001	WO2001010847A3 Novel integrin receptor antagonists
11/01/2001	WO2001005937A3 Conversion of a watson-crick dna to a hoogsteen-paired duplex
11/01/2001	WO2000066111A9 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/01/2001	WO2000056742A9 Organic-arsenic compounds
11/01/2001	WO2000048463A9 Method for preparation of pharmaceutical-grade dithiocarbamate
11/01/2001	WO2000044333A3 Novel injectable antimalarial compositions of artemisinin
11/01/2001	WO2000024780A9 Compositions and methods for treating polycystic kidney disease
11/01/2001	WO1999013816A3 Liposomal camptothecin formulations
11/01/2001	US20010037040 Acetamidobenzamide compounds for neurodegenerative disorders
11/01/2001	US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001	US20010037026 Reacting a protected amino acid ester with a 4-substituted butyric acid derivative, cyclizing the protected intermediate, benzylating and decarboxylating the intermediate, asymmetric hydrogenation using a catalyst
11/01/2001	US20010037025 Benzopyran, benzothiopyran or benzoquinone derivatives are useful in the treatment of ailments and disorders where a reduction of blood glucose is benefical, such as diabetes
11/01/2001	US20010037021 11-keto-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo(c,f)( 1,2)thiazepine is reacted with sodium borohydride in presence of chlorinated solvent and a catalyst to form alcohol, then chlorinating to form chloride, finally forming a salt
11/01/2001	US20010037020 Method for preparation of taxol
11/01/2001	US20010037019 A mixture of salt of 7-amino-3-methyl-cephalosporanic acid (7-ADCA) and a salt of 7-amino-3-vinyl-cephalosporanic acid is subjected to crystallization, isolating crystal salt, converted into 7-ADCA, then performing chromatography
11/01/2001	US20010036963 Octenidine dihydrochloride, C1 to C8-alkyl alcohol, alkylpolyglycoside non-ionic and quaternary betaine cationic surfactants, water, alpha-hydroxycarboxylic acid
11/01/2001	US20010036962 Self-emulsifying systems containing anticancer medicament
11/01/2001	US20010036960 Carvedilol-lipophilic solutions
11/01/2001	US20010036959 Carvedilol-hydrophilic solutions
11/01/2001	US20010036958 Antiinflammatory agents, antiasthmatics
11/01/2001	US20010036957 Diabetic neuropathy, nephropathy, ophthalimopathy, arteriosclerosis
11/01/2001	US20010036956 Estrogen receptor modulators
11/01/2001	US20010036955 Method of inhibiting angiogenesis
11/01/2001	US20010036954 Use of calcium channel blocker optionally in the presence of a anti-hypertensive agent
11/01/2001	US20010036953 Pyridyl-1,2,5-thiadiazole derivatives
11/01/2001	US20010036952 Treatment of alopecia
11/01/2001	US20010036951 Administering to a patient an effective amount of a peripheral mu opioid antagonist compound, including piperidine-N-alkylcarboxylates, quaternary morphinans, opium alkaloid derivatives
11/01/2001	US20010036950 Potassium channel openers
11/01/2001	US20010036949 Pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal
11/01/2001	US20010036948 Administering a vascular alkylating compound; prevention restenosis
11/01/2001	US20010036947 Pipecolic acid derivative hair growth compositions and uses
11/01/2001	US20010036946 Antiinflammatory agents
11/01/2001	US20010036945 Certain Isoquinolinamine and phthalazinamine derivatives; corticotropin-releasing factor receptor CRF1 specific ligands
11/01/2001	US20010036944 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
11/01/2001	US20010036943 Mixture of analgesic and carrier
11/01/2001	US20010036942 Nervous system disorders
11/01/2001	US20010036941 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolonecarboxylic acid and -naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and associated gastroduodenal disorders
11/01/2001	US20010036940 Chemical intermediates
11/01/2001	US20010036939 Apoptosis therapy
11/01/2001	US20010036938 Use of oral beclomethasone dipropionate to treat liver inflammation
11/01/2001	US20010036937 Intensive care unit
11/01/2001	US20010036936 Compositions and methods for treating osteoporosis
11/01/2001	US20010036934 Antiinflammatory agents
11/01/2001	US20010036932 Cardiovascular disorders
11/01/2001	US20010036930 Therapeutic azide compounds
11/01/2001	US20010036927 Complexing
11/01/2001	US20010036924 Dietetics, immunomodulator, antiinflammatory agents
11/01/2001	US20010036923 Complex
11/01/2001	US20010036922 Method of treating a parasitic infection
11/01/2001	US20010036920 Method for treating papillomavirus infections
11/01/2001	US20010036919 Preventing airway mucus production by administration of EGF-R antagonists
11/01/2001	US20010036898 Activating catalyst; reducing by-products
11/01/2001	US20010036655 Vaccine
11/01/2001	US20010036635 Cancer screening
11/01/2001	US20010036502 Oil composition
11/01/2001	US20010036500 For enriching foods or beverages, anemia treatment
11/01/2001	US20010036490 In combination with a cyclooxygenase inhibitor, an acid, a mucolytic and a salicin-containing herb; for supplementing dietary chromium and facilitating absorption of essential metals
11/01/2001	US20010036487 Proanthocyanidin-containing composition
11/01/2001	US20010036483 Administering drug to localized region of human patient's body surface in combination with hydroxide releasing agent applied to body surface

1 ... 5977 5978 5979 5980 5981 5982 5983 5984 5985 5986 5987 5988 5989 5990 5991 5992 5993 5994 5995 5996 5997 ... 7860